Advertisement
New Zealand markets close in 1 hour 36 minutes
  • NZX 50

    11,737.40
    -98.64 (-0.83%)
     
  • NZD/USD

    0.5872
    -0.0034 (-0.57%)
     
  • NZD/EUR

    0.5519
    -0.0026 (-0.46%)
     
  • ALL ORDS

    7,777.40
    -121.50 (-1.54%)
     
  • ASX 200

    7,527.60
    -114.50 (-1.50%)
     
  • OIL

    85.30
    +2.57 (+3.11%)
     
  • GOLD

    2,405.80
    +7.80 (+0.33%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,086.65
    -299.22 (-1.83%)
     
  • NIKKEI 225

    36,818.81
    -1,260.89 (-3.31%)
     
  • NZD/JPY

    90.4850
    -0.7690 (-0.84%)
     

Is Teva Pharmaceuticals Stock a Buy?

Is Teva Pharmaceuticals Stock a Buy?

Teva Pharmaceutical Industries (NYSE: TEVA) is a well known generic drugmaker that's attracted the attention of a number of well-known investors in the past. Most notably, Warren Buffett's Berkshire Hathaway bought shares of the company a number of years ago due, in no small part due to how cheap the stock was at the time. Teva's business can be split up into two main areas: its generics business and its own branded drug products.